Trulieve Cannabis Corp. (TRLV) Stock Forecast
TRLV analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.86 / 5 from 7 analysts
- Price target
- $18.18 average of analyst targets
- Upside to target
- +81.6% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.09
- 52-week range
- $7.26 – $13.00
TRLV analyst ratings
7 analystsNumber of analysts at each rating.
TRLV price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TRLV earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.07 | $0.02 | $0.12 | −$0.07 | +200.0% | 2 |
| Current fiscal year (2026) | −$1.82 | −$2.05 | −$1.63 | −$0.61 | −198.8% | 5 |
| Next fiscal year (2027) | $0.56 | $0.42 | $0.66 | −$1.84 | +130.2% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TRLV revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $221.6M | $221.0M | $222.0M | −23.1% | 3 |
| Current fiscal year (2026) | $1.01B | $1.01B | $1.01B | −14.6% | 3 |
| Next fiscal year (2027) | $936.4M | $905.9M | $988.0M | −7.2% | 6 |
TRLV EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TRLV revenue: reported and forecast
TRLV EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.03 | $0.01 | $0.07 | $0.07 | $0.07 | +133.3% | 1 up · 0 down |
| Current fiscal year (2026) | $0.21 | $0.21 | −$1.82 | −$1.82 | −$1.82 | −981.9% | 0 up · 3 down |
| Next fiscal year (2027) | $0.24 | $0.24 | $0.56 | $0.56 | $0.56 | +132.4% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TRLV earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TRLV beat in 9 of 9.
What analysts expect from TRLV
7 analysts cover Trulieve Cannabis; their consensus rating is strong buy (4.86 on a 1–5 scale, where 5 is a strong buy). The average price target is $18.18, 81.6% above the latest close of $10.01. Analysts expect earnings of −$1.82 per share for 2026, −198.8% from a year earlier. For 2027 the average estimate is $0.56 per share on revenue of $936.4 million. Trulieve Cannabis beat the EPS estimate in 9 of the last 9 quarters.
Related: TRLV income statement, TRLV key metrics, TRLV chart. See the TRLV stock overview for the latest quote and news.
TRLV forecast FAQ
What is Trulieve Cannabis's price target?
The average analyst price target for Trulieve Cannabis is $18.18, 81.6% above the latest close of $10.01.
Is Trulieve Cannabis a buy, hold or sell?
Of 7 analysts covering Trulieve Cannabis, 6 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Trulieve Cannabis's EPS forecast?
Analysts forecast −$1.82 per share for 2026 (range −$2.05 to −$1.63); for 2027 the estimate is $0.56.
What is Trulieve Cannabis's revenue forecast?
The average revenue estimate for 2026 is $1.0 billion, growth of −14.6%; for 2027 it is $936.4 million.
When does Trulieve Cannabis report earnings?
Trulieve Cannabis is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $0.09.
Does Trulieve Cannabis usually beat earnings estimates?
Trulieve Cannabis reported EPS at or above the analyst estimate in 9 of the last 9 quarters.